vs
Cytek Biosciences, Inc.（CTKB）与HomeTrust Bancshares, Inc.（HTB）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是HomeTrust Bancshares, Inc.的1.2倍（$62.1M vs $53.6M），Cytek Biosciences, Inc.同比增速更快（8.1% vs 3.7%），HomeTrust Bancshares, Inc.自由现金流更多（$45.3M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 3.5%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
HomeTrust Bancshares, Inc.是总部位于美国北卡罗来纳州阿什维尔的银行控股公司，总资产达43亿美元，在北卡、南卡、佐治亚和田纳西州共设有33家网点，旗下拥有HomeTrust银行、Tryon联邦银行等七家社区银行。
CTKB vs HTB — 直观对比
营收规模更大
CTKB
是对方的1.2倍
$53.6M
营收增速更快
CTKB
高出4.5%
3.7%
自由现金流更多
HTB
多$47.1M
$-1.8M
两年增速更快
CTKB
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $53.6M |
| 净利润 | $-44.1M | — |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | 37.0% |
| 净利率 | -70.9% | — |
| 营收同比 | 8.1% | 3.7% |
| 净利润同比 | -557.1% | — |
| 每股收益（稀释后） | — | $0.93 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBHTB
| Q4 25 | $62.1M | $53.6M | ||
| Q3 25 | $52.3M | $54.1M | ||
| Q2 25 | $45.6M | $54.4M | ||
| Q1 25 | $41.5M | $50.9M | ||
| Q4 24 | $57.5M | $51.7M | ||
| Q3 24 | $51.5M | $50.6M | ||
| Q2 24 | $46.6M | $50.6M | ||
| Q1 24 | $44.9M | $50.0M |
净利润CTKBHTB
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $16.5M | ||
| Q2 25 | $-5.6M | $17.2M | ||
| Q1 25 | $-11.4M | $14.5M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $941.0K | $13.1M | ||
| Q2 24 | $-10.4M | $12.4M | ||
| Q1 24 | $-6.2M | $15.1M |
毛利率CTKBHTB
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBHTB
| Q4 25 | -9.0% | 37.0% | ||
| Q3 25 | -17.6% | 38.5% | ||
| Q2 25 | -23.3% | 40.1% | ||
| Q1 25 | -36.1% | 36.2% | ||
| Q4 24 | 5.2% | 35.4% | ||
| Q3 24 | -8.2% | 33.2% | ||
| Q2 24 | -18.3% | 31.3% | ||
| Q1 24 | -23.9% | 38.0% |
净利率CTKBHTB
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | 30.5% | ||
| Q2 25 | -12.2% | 31.6% | ||
| Q1 25 | -27.5% | 28.5% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 1.8% | 25.9% | ||
| Q2 24 | -22.4% | 24.6% | ||
| Q1 24 | -13.8% | 30.1% |
每股收益（稀释后）CTKBHTB
| Q4 25 | — | $0.93 | ||
| Q3 25 | — | $0.95 | ||
| Q2 25 | — | $1.00 | ||
| Q1 25 | — | $0.84 | ||
| Q4 24 | — | $0.83 | ||
| Q3 24 | — | $0.76 | ||
| Q2 24 | — | $0.73 | ||
| Q1 24 | — | $0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $324.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $600.7M |
| 总资产 | $461.5M | $4.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBHTB
| Q4 25 | $90.9M | $324.7M | ||
| Q3 25 | $93.3M | $315.8M | ||
| Q2 25 | $75.5M | $297.2M | ||
| Q1 25 | $95.3M | $299.8M | ||
| Q4 24 | $98.7M | $279.2M | ||
| Q3 24 | $162.3M | $293.5M | ||
| Q2 24 | $177.9M | $294.2M | ||
| Q1 24 | $168.8M | $380.5M |
股东权益CTKBHTB
| Q4 25 | $341.7M | $600.7M | ||
| Q3 25 | $378.6M | $595.8M | ||
| Q2 25 | $377.6M | $579.3M | ||
| Q1 25 | $379.6M | $565.4M | ||
| Q4 24 | $395.7M | $551.8M | ||
| Q3 24 | $385.5M | $540.0M | ||
| Q2 24 | $389.1M | $523.6M | ||
| Q1 24 | $392.6M | $513.2M |
总资产CTKBHTB
| Q4 25 | $461.5M | $4.5B | ||
| Q3 25 | $494.9M | $4.6B | ||
| Q2 25 | $493.3M | $4.6B | ||
| Q1 25 | $482.6M | $4.6B | ||
| Q4 24 | $499.5M | $4.6B | ||
| Q3 24 | $491.2M | $4.6B | ||
| Q2 24 | $483.7M | $4.7B | ||
| Q1 24 | $492.1M | $4.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $49.5M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $45.3M |
| 自由现金流率自由现金流/营收 | -2.9% | 84.5% |
| 资本支出强度资本支出/营收 | 1.6% | 7.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $93.8M |
8季度趋势，按日历期对齐
经营现金流CTKBHTB
| Q4 25 | $-771.0K | $49.5M | ||
| Q3 25 | $-3.9M | $-11.3M | ||
| Q2 25 | $108.0K | $-8.8M | ||
| Q1 25 | $-125.0K | $71.7M | ||
| Q4 24 | $2.0M | $45.4M | ||
| Q3 24 | $13.2M | $43.8M | ||
| Q2 24 | $6.2M | $5.9M | ||
| Q1 24 | $4.0M | $-9.0M |
自由现金流CTKBHTB
| Q4 25 | $-1.8M | $45.3M | ||
| Q3 25 | $-4.6M | $-12.0M | ||
| Q2 25 | $-1.5M | $-10.2M | ||
| Q1 25 | $-974.0K | $70.7M | ||
| Q4 24 | $1.1M | $42.4M | ||
| Q3 24 | $12.2M | $43.1M | ||
| Q2 24 | $5.2M | $5.7M | ||
| Q1 24 | $3.4M | $-9.6M |
自由现金流率CTKBHTB
| Q4 25 | -2.9% | 84.5% | ||
| Q3 25 | -8.7% | -22.2% | ||
| Q2 25 | -3.2% | -18.7% | ||
| Q1 25 | -2.3% | 138.7% | ||
| Q4 24 | 1.9% | 82.0% | ||
| Q3 24 | 23.7% | 85.1% | ||
| Q2 24 | 11.0% | 11.2% | ||
| Q1 24 | 7.6% | -19.2% |
资本支出强度CTKBHTB
| Q4 25 | 1.6% | 7.8% | ||
| Q3 25 | 1.3% | 1.4% | ||
| Q2 25 | 3.5% | 2.5% | ||
| Q1 25 | 2.0% | 2.0% | ||
| Q4 24 | 1.6% | 5.9% | ||
| Q3 24 | 2.0% | 1.3% | ||
| Q2 24 | 2.3% | 0.5% | ||
| Q1 24 | 1.3% | 1.1% |
现金转化率CTKBHTB
| Q4 25 | — | — | ||
| Q3 25 | — | -0.68× | ||
| Q2 25 | — | -0.51× | ||
| Q1 25 | — | 4.93× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 3.34× | ||
| Q2 24 | — | 0.48× | ||
| Q1 24 | — | -0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
HTB
暂无分部数据
